![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
1. Roxatidine Acetate
2. Roxatidine Acetate Hydrochloride
3. Roxiwas
4. Zarocs
1. 78273-80-0
2. Desacetyl-tzu-0460
3. 2-hydroxy-n-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide
4. Iv9vht3yum
5. Roxatidine (inn)
6. Roxatidine [inn]
7. Roxatidine [inn:ban]
8. Unii-iv9vht3yum
9. 2-hydroxy-n-(3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)acetamide
10. 2-hydroxy-n-{3-[3-(1-piperidinylmethyl)phenoxy]propyl}acetamide
11. 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)acetamide
12. Roxit (tn)
13. 2-hydroxy-n-[3-[3-(1-piperidylmethyl)phenoxy]propyl]acetamide
14. Roxatidine [vandf]
15. Schembl1394
16. Roxatidine [who-dd]
17. Chembl4802233
18. Dtxsid30228937
19. Bcp13552
20. Zinc1541892
21. Acetamide, 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
22. Mfcd00871807
23. Akos015896584
24. Sy293181
25. Hy-137941
26. Cs-0143056
27. Ft-0756141
28. D08494
29. 273r800
30. L012909
31. Q415039
32. Sr-01000944538
33. Sr-01000944538-1
34. N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]hydroxyacetamide
Molecular Weight | 306.4 g/mol |
---|---|
Molecular Formula | C17H26N2O3 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 306.19434270 g/mol |
Monoisotopic Mass | 306.19434270 g/mol |
Topological Polar Surface Area | 61.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 319 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Histamine H2 Antagonists
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BA - H2-receptor antagonists
A02BA06 - Roxatidine